Skip to main content
Journal cover image

Positive margins: is adjunctive radiation therapy indicated?

Publication ,  Journal Article
Paulson, DF; Robertson, CN
Published in: Acta Oncol
1991

Patients with margin positive disease after radical prostatectomy are prognostically disadvantaged. The question of postoperative adjunctive radiotherapy in these patients is controversial. A retrospective study suggested that adjunctive radiation therapy reduced the local recurrence rate but did not alter survival.

Duke Scholars

Published In

Acta Oncol

DOI

ISSN

0284-186X

Publication Date

1991

Volume

30

Issue

2

Start / End Page

263 / 265

Location

Sweden

Related Subject Headings

  • Survival Rate
  • Prostatic Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Recurrence, Local
  • Male
  • Humans
  • Combined Modality Therapy
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Paulson, D. F., & Robertson, C. N. (1991). Positive margins: is adjunctive radiation therapy indicated? Acta Oncol, 30(2), 263–265. https://doi.org/10.3109/02841869109092366
Paulson, D. F., and C. N. Robertson. “Positive margins: is adjunctive radiation therapy indicated?Acta Oncol 30, no. 2 (1991): 263–65. https://doi.org/10.3109/02841869109092366.
Paulson DF, Robertson CN. Positive margins: is adjunctive radiation therapy indicated? Acta Oncol. 1991;30(2):263–5.
Paulson, D. F., and C. N. Robertson. “Positive margins: is adjunctive radiation therapy indicated?Acta Oncol, vol. 30, no. 2, 1991, pp. 263–65. Pubmed, doi:10.3109/02841869109092366.
Paulson DF, Robertson CN. Positive margins: is adjunctive radiation therapy indicated? Acta Oncol. 1991;30(2):263–265.
Journal cover image

Published In

Acta Oncol

DOI

ISSN

0284-186X

Publication Date

1991

Volume

30

Issue

2

Start / End Page

263 / 265

Location

Sweden

Related Subject Headings

  • Survival Rate
  • Prostatic Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Recurrence, Local
  • Male
  • Humans
  • Combined Modality Therapy
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis